Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Neoplasm in the Viscera”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07608718
What this trial is testing

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Pedro Barata, MD, MSc 19
Post-approval studies (Phase 4)Ended earlyNCT04031885
What this trial is testing

Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 4
Testing effectiveness (Phase 2)Study completedNCT01834651
What this trial is testing

A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases

Who this might be right for
Prostate Cancer
Edwin Posadas, MD 17
Testing effectiveness (Phase 2)Study completedNCT01253096
What this trial is testing

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 25
Testing effectiveness (Phase 2)Ended earlyNCT01082887
What this trial is testing

Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03793166
What this trial is testing

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more
National Cancer Institute (NCI) 1,175
Testing effectiveness (Phase 2)Study completedNCT02687490
What this trial is testing

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 81
Testing effectiveness (Phase 2)WithdrawnNCT03448666
What this trial is testing

ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

Who this might be right for
Malignant Melanoma
European Institute of Oncology
Large-scale testing (Phase 3)UnknownNCT04337658
What this trial is testing

Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 493
Not applicableStudy completedNCT04681768
What this trial is testing

Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer/ Metastatic Breast Cancer
Technical University of Munich 95